ArticleTurkish journal of medical sciences2025
Characteristics and complications of uveitis in patients referred to rheumatology: a single-center study.
Article in Turkish journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: To evaluate the clinical, demographic, and complication data of patients with new-onset uveitis at the ophthalmology and rheumatology departments of a single center. Materials and methods: This retrospective study included patients newly diagnosed with uveitis who were referred to the rheumatology department for etiological evaluation between August 2021 and August 2024. Patients with a history of rheumatologic diseases associated with uveitis were not included in the study. Results: A total of 91 patients (female: n = 59, 65%) who met the inclusion criteria were enrolled in the study. The mean age at uveitis diagnosis was 45.7 ± 14.8 years. The most common form of uveitis was anterior uveitis (81.3%), followed by intermediate uveitis (14.3%) and panuveitis (4.4%). About one-third of the patients had a rheumatologic etiology (n = 29, 31.9%), with spondyloarthritis being the most common. Approximately one in five patients with newly diagnosed uveitis of rheumatologic etiology developed ocular complications (n = 5, 17.2%), 80% (n = 4) of whom had anterior uveitis and 20% (n = 1) of whom had panuveitis. Macular edema was the most common ocular complication. Conclusion: Anterior uveitis is generally regarded as more benign, but it still carries a risk of complications. Timely identification and management of systemic autoimmune diseases associated with uveitis may provide a valuable opportunity to prevent ocular complications and visual impairment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.